RDY News and Press, Dr. Reddy's Laboratories Ltd From 12/24/23

2023-12-24 02:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-14 12:30:25 ET The Biden administration on Thursday named 48 Medicare Part B drugs that could be subject to inflation penalties for Q1 2024, including products from the likes of AbbVie ( NYSE: ABBV ), Amgen ( NASDAQ: AMGN ), and Pfizer ( NYSE: PFE ). Drug...

Company also secures ‘Gold Medal’ status from global sustainability ratings agency, EcoVadis In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the Dow Jones Sustainability ...

2023-12-11 12:23:16 ET More on Dr. Reddy's Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements Dr Reddy's Laboratories Ltd (RDY) Q2 2024 Earnings Call Transcript Dr. Reddy's: Continued Q2 Earnings Growth, Supports Long-Term Investme...

2023-12-06 07:40:06 ET More on Coya Therapeutics Historical earnings data for Coya Therapeutics Financial information for Coya Therapeutics For further details see: Dr Reddy's licenses Coya ALS candidate in exclusive deal

Under the Agreement, Dr. Reddy’s will obtain commercialization rights for COYA 302 in the United States, Canada, the European Union and the United Kingdom, for patients with ALS COYA will be responsible for development, including the conduct of the Phase 2 clinical trial and fo...

2023-12-01 13:40:47 ET More on Amarin, Amneal, etc. Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Amarin Corporation plc (AMRN) Q3 2023 Earnings Call Transcript ...

2023-11-29 01:15:52 ET Summary Dr. Reddy's Laboratories reports impressive financial results, with record-breaking sales and profitability in their recent quarter. The company shows strong growth in their India, North America, Europe, and Emerging Markets businesses. Dr. Reddy...

2023-11-16 15:00:31 ET More on Dr. Reddy's Dr Reddy's Laboratories Ltd (RDY) Q2 2024 Earnings Call Transcript Dr. Reddy's: Continued Q2 Earnings Growth, Supports Long-Term Investment Outlook Dr. Reddy's: Growth Supported By New Labels, Profitability Seeking A...

2023-10-27 14:48:06 ET Dr Reddy’s Laboratories Ltd (RDY) Q2 2024 Earnings Conference Call October 27, 2023, 10:00 ET Company Participants Richa Periwal - IR Parag Agarwal - CFO Erez Israeli - CEO Conference Call Participants Mikaela Franceschin...